302 related articles for article (PubMed ID: 35054318)
21. Homeostasis of iron and hepcidin in erythropoietic protoporphyria.
Bossi K; Lee J; Schmeltzer P; Holburton E; Groseclose G; Besur S; Hwang S; Bonkovsky HL
Eur J Clin Invest; 2015 Oct; 45(10):1032-41. PubMed ID: 26199063
[TBL] [Abstract][Full Text] [Related]
22. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI
Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505
[TBL] [Abstract][Full Text] [Related]
23. Liver metabolomics in a mouse model of erythropoietic protoporphyria.
Wang P; Sachar M; Guo GL; Shehu AI; Lu J; Zhong XB; Ma X
Biochem Pharmacol; 2018 Aug; 154():474-481. PubMed ID: 29906468
[TBL] [Abstract][Full Text] [Related]
24. Mild iron deficiency does not ameliorate the phenotype of a murine erythropoietic protoporphyria model.
Schmidt PJ; Hollowell ML; Fitzgerald K; Butler JS; Fleming MD
Am J Hematol; 2020 May; 95(5):492-496. PubMed ID: 31990410
[TBL] [Abstract][Full Text] [Related]
25. Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members.
Berroeta L; Man I; Goudie DR; Whatley SD; Elder GH; Ibbotson SH
Br J Dermatol; 2007 Nov; 157(5):1030-1. PubMed ID: 17711525
[TBL] [Abstract][Full Text] [Related]
26. Distribution of protoporphyrin IX in erythrocytes in a case of acquired erythropoietic protoporphyria.
Heerfordt IM; Fontenete S; Lerche CM; Wulf HC
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102629. PubMed ID: 34798346
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal Analysis of Erythrocyte and Plasma Protoporphyrin Levels in Patients with Protoporphyria.
Gou E; Weng C; Greene T; Anderson KE; Phillips JD
J Appl Lab Med; 2018 Sep; 3(2):213-221. PubMed ID: 33636932
[TBL] [Abstract][Full Text] [Related]
28. Accumulation of protoporphyrin IX from delta-aminolevulinic acid in bovine skin fibroblasts with hereditary erythropoietic protoporphyria. A gene-dosage effect.
Sassa S; Schwartz S; Ruth G
J Exp Med; 1981 May; 153(5):1094-101. PubMed ID: 6788885
[TBL] [Abstract][Full Text] [Related]
29. Ursodesoxycholic acid and heme-arginate are unable to improve hematopoiesis and liver injury in an erythropoietic protoporphyria mouse model.
Abitbol M; Puy H; Sabaté JM; Guénet JL; Deybach JC; Montagutelli X
Physiol Res; 2006; 55 Suppl 2():S93-101. PubMed ID: 17298226
[TBL] [Abstract][Full Text] [Related]
30. Results of a pilot study of isoniazid in patients with erythropoietic protoporphyria.
Parker CJ; Desnick RJ; Bissel MD; Bloomer JR; Singal A; Gouya L; Puy H; Anderson KE; Balwani M; Phillips JD
Mol Genet Metab; 2019 Nov; 128(3):309-313. PubMed ID: 31395332
[TBL] [Abstract][Full Text] [Related]
31. Excessive erythrocyte PPIX influences the hematologic status and iron metabolism in patients with dominant erythropoietic protoporphyria.
Delaby C; Lyoumi S; Ducamp S; Martin-Schmitt C; Gouya L; Deybach JC; Beaumont C; Puy H
Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):45-52. PubMed ID: 19268001
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the iron-sulfur cluster ligands of the human ferrochelatase lead to erythropoietic protoporphyria.
Schneider-Yin X; Gouya L; Dorsey M; Rüfenacht U; Deybach JC; Ferreira GC
Blood; 2000 Aug; 96(4):1545-9. PubMed ID: 10942404
[TBL] [Abstract][Full Text] [Related]
33. Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy.
Ventura P; Brancaleoni V; Di Pierro E; Graziadei G; Macrì A; Carmine Guida C; Nicolli A; Rossi MT; Granata F; Fiorentino V; Fustinoni S; Sala R; Pinton PC; Trevisan A; Marchini S; Cuoghi C; Marcacci M; Corradini E; Sorge F; Aurizi C; Savino MG; Cappellini MD; Pietrangelo A
Eur J Dermatol; 2020 Oct; 30(5):532-540. PubMed ID: 33021473
[TBL] [Abstract][Full Text] [Related]
34. Protoporphyrin accumulation by mitogen stimulated lymphocytes and protoporphyrinogen oxidase activity in patients with porphyria variegata and erythropoietic protoporphyria: evidence for deficiency of protoporphyrinogen oxidase and ferrochelatase in both diseases.
Siepker LJ; Kramer S
Br J Haematol; 1985 May; 60(1):65-74. PubMed ID: 3924091
[TBL] [Abstract][Full Text] [Related]
35. Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria.
Mirmiran A; Schmitt C; Lefebvre T; Manceau H; Daher R; Oustric V; Poli A; Lacapère JJ; Moulouel B; Puy H; Karim Z; Peoc'h K; Lenglet H; Simonin S; Deybach JC; Nicolas G; Gouya L
Am J Hum Genet; 2019 Feb; 104(2):341-347. PubMed ID: 30712775
[TBL] [Abstract][Full Text] [Related]
36. Molecular epidemiology of erythropoietic protoporphyria in the U.K.
Whatley SD; Mason NG; Holme SA; Anstey AV; Elder GH; Badminton MN
Br J Dermatol; 2010 Mar; 162(3):642-6. PubMed ID: 20105171
[TBL] [Abstract][Full Text] [Related]
37. Effects of iron supplements in individuals with erythropoietic protoporphyria.
Heerfordt IM; Lerche CM; Philipsen PA; Wulf HC
Photodiagnosis Photodyn Ther; 2024 May; 47():104211. PubMed ID: 38734198
[TBL] [Abstract][Full Text] [Related]
38. Liver transplantation for acute-on-chronic liver failure from erythropoietic protoporphyria.
Park PJ; Hwang S; Choi YI; Yu YD; Park GC; Jung SW; Yoon SY; Song GW; Ha TY; Lee SG
Clin Mol Hepatol; 2012 Dec; 18(4):411-5. PubMed ID: 23323258
[TBL] [Abstract][Full Text] [Related]
39. New insights into the pathogenesis of erythropoietic protoporphyria and their impact on patient care.
Schneider-Yin X; Gouya L; Meier-Weinand A; Deybach JC; Minder EI
Eur J Pediatr; 2000 Oct; 159(10):719-25. PubMed ID: 11039124
[TBL] [Abstract][Full Text] [Related]
40. The role of ClpX in erythropoietic protoporphyria.
Whitman JC; Paw BH; Chung J
Hematol Transfus Cell Ther; 2018; 40(2):182-188. PubMed ID: 30057992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
